TOSYMRA is a Nasal Spray in the Human Prescription Drug category. It is labeled and distributed by Upsher-smith Laboratories, Llc. The primary component is Sumatriptan.
| Product ID | 0245-0812_a39c33cb-bf6c-4730-8159-49c7c02b224a |
| NDC | 0245-0812 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOSYMRA |
| Generic Name | Sumatriptan |
| Dosage Form | Spray |
| Route of Administration | NASAL |
| Marketing Start Date | 2019-07-08 |
| Marketing Category | NDA / |
| Application Number | NDA210884 |
| Labeler Name | Upsher-Smith Laboratories, LLC |
| Substance Name | SUMATRIPTAN |
| Active Ingredient Strength | 10 mg/.1mL |
| Pharm Classes | Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-09-01 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0245-0812 | TOSYMRA | sumatriptan |
| 67857-812 | TOSYMRA | TOSYMRA |
| 0173-0449 | IMITREX | sumatriptan |
| 0173-0478 | IMITREX | sumatriptan |
| 0173-0479 | IMITREX | sumatriptan |
| 0173-0523 | IMITREX | sumatriptan |
| 0173-0524 | IMITREX | sumatriptan |
| 0173-0735 | IMITREX | sumatriptan |
| 0173-0736 | IMITREX | sumatriptan |
| 0173-0737 | IMITREX | sumatriptan |
| 0173-0739 | IMITREX | sumatriptan |
| 0143-9638 | SUMATRIPTAN | sumatriptan |
| 0527-1818 | Sumatriptan | Sumatriptan |
| 0527-1859 | Sumatriptan | Sumatriptan |
| 0781-6523 | SUMATRIPTAN | sumatriptan |
| 0781-6524 | SUMATRIPTAN | sumatriptan |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TOSYMRA 88775112 not registered Live/Pending |
UPSHER-SMITH LABORATORIES, LLC 2020-01-27 |
![]() TOSYMRA 88390100 not registered Live/Pending |
UPSHER-SMITH LABORATORIES, LLC 2019-04-17 |
![]() TOSYMRA 87815803 not registered Live/Pending |
Promius Pharma, LLC 2018-03-01 |